The effects of safinamide according to gender in Chinese parkinsonian patients
Abstract The incidence and prevalence of Parkinson’s disease (PD) is expected to raise dramatically over the next decades. Gender-related differences are not yet widely recognized, particularly regarding the response to dopaminergic medications. To analyse gender differences in the clinical effects...
Main Authors: | M. T. Pellecchia, M. Picillo, M. C. Russillo, V. Andreozzi, C. Oliveros, C. Cattaneo |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-48067-8 |
Similar Items
-
Efficacy of Safinamide and Gender Differences During Routine Clinical Practice
by: Maria T. Pellecchia, et al.
Published: (2021-12-01) -
Hypersexuality associated with safinamide
by: A. Puy-Núñez, et al.
Published: (2020-09-01) -
The effects of safinamide on dysphagia in Parkinson’s disease
by: Makito Hirano, et al.
Published: (2023-01-01) -
The effects of safinamide on dysphagia in Parkinson's disease.
by: Makito Hirano, et al.
Published: (2023-01-01) -
Effects of safinamide on pain in patients with fluctuating Parkinson's disease
by: Sotirios Grigoriou, et al.
Published: (2021-10-01)